Genetic variability in CHMP2B and frontotemporal dementia

被引:42
作者
Momeni, Parastoo
Rogaeva, Ekaterina
Van Deerlin, Vivianna
Yuan, Wuxing
Grafman, Jordan
Tierney, Michael
Huey, Edward
Bell, Jason
Morris, Chris M.
Kalaria, Rajesh N.
van Rensburg, Susan J.
Niehaus, Dana
Potocnik, Felix
Kawarai, Toshitaka
Salehi-Rad, Shabnam
Sato, Christine
George-Hyslop, Peter St.
Hardy, John
机构
[1] NIA, Neurogenet Lab, Bethesda, MD 20892 USA
[2] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON, Canada
[3] Univ Penn, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis, Philadelphia, PA 19104 USA
[4] NINDS, Cognit Neurosci Sect, NIH, Bethesda, MD 20892 USA
[5] Newcastle Gen Hosp, Inst Hlth & Ageing, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
[6] Newcastle Gen Hosp, Hlth Protect Agcy, Chem Hazards & Poisons Div, Wolfson Unit Chem Pharmacol, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
[7] Univ Stellenbosch, Dept Psychiat, ZA-7505 Tygerberg, South Africa
基金
英国医学研究理事会;
关键词
frontotemporal dementia; chromosome; 3; MAPT; CHMP2B;
D O I
10.1159/000094771
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A nonsense/protein chain-terminating mutation in the CHMP2B gene has recently been reported as a cause of frontotemporal dementia (FTD) in the single large family known to show linkage to chromosome 3. Screening for mutations in this gene in a large series of FTD families and individual patients led to the identification of a protein-truncating mutation in 2 unaffected members of an Afrikaner family with FTD, but not in their affected relatives. The putative pathogenicity of CHMP2B mutations for dementia is discussed. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:129 / 133
页数:5
相关论文
共 9 条
[1]   FAMILIAL NONSPECIFIC DEMENTIA MAPS TO CHROMOSOME-3 [J].
BROWN, J ;
ASHWORTH, A ;
GYDESEN, S ;
SORENSEN, A ;
ROSSOR, M ;
HARDY, J ;
COLLINGE, J .
HUMAN MOLECULAR GENETICS, 1995, 4 (09) :1625-1628
[2]   NEUROPSYCHIATRIC STUDIES IN A FAMILY WITH PRESENILE-DEMENTIA DIFFERENT FROM ALZHEIMER AND PICK DISEASE [J].
GYDESEN, S ;
HAGEN, S ;
KLINKEN, L ;
ABELSKOV, J ;
SORENSEN, SA .
ACTA PSYCHIATRICA SCANDINAVICA, 1987, 76 (03) :276-284
[3]  
Houlden H, 1999, ANN NEUROL, V46, P243, DOI 10.1002/1531-8249(199908)46:2<243::AID-ANA14>3.0.CO
[4]  
2-L
[5]   The genetic and pathological classification of familial frontotemporal dementia [J].
Morris, HR ;
Khan, MN ;
Janssen, JC ;
Brown, JM ;
Perez-Tur, J ;
Baker, M ;
Ozansoy, M ;
Hardy, J ;
Hutton, M ;
Wood, NW ;
Lees, AJ ;
Revesz, T ;
Lantos, P ;
Rossor, MN .
ARCHIVES OF NEUROLOGY, 2001, 58 (11) :1813-1816
[6]   The role of tau (MAPT) in frontotemporal dementia and related tauopathies [J].
Rademakers, R ;
Cruts, M ;
van Broeckhoven, C .
HUMAN MUTATION, 2004, 24 (04) :277-295
[7]   Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia [J].
Skibinski, G ;
Parkinson, NJ ;
Brown, JM ;
Chakrabarti, L ;
Lloyd, SL ;
Hummerich, H ;
Nielsen, JE ;
Hodges, JR ;
Spillantini, MG ;
Thusgaard, T ;
Brandner, S ;
Brun, A ;
Rossor, MN ;
Gade, A ;
Johannsen, P ;
Sorensen, SA ;
Gydesen, S ;
Fisher, EMC ;
Collinge, J .
NATURE GENETICS, 2005, 37 (08) :806-808
[8]  
Vidal R, 1999, NATURE, V399, P776
[9]   Tau protein in frontotemporal dementia linked to chromosome 3 (FTD-3) [J].
Yancopoulu, D ;
Crowther, RA ;
Chakrabarti, U ;
Gydesen, S ;
Brown, JM ;
Spillantini, MG .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2003, 62 (08) :878-882